EP0089
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EP0089, covering 2025-06-22 to 2025-06-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of EP0089 [Phase 1, Phase 2]